ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Protagonist Therapeutics Inc

Protagonist Therapeutics Inc (PTGX)

37,59
1,25
(3,44%)
Geschlossen 01 März 10:00PM
37,5911
0,0011
(0,00%)
Nach Börsenschluss: 1:59AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
37,59
Gebot
35,27
Fragen
38,00
Volumen
720.439
35,97 Tagesbereich 37,66
24,22 52-Wochen-Bereich 48,89
Marktkapitalisierung
Handelsende
36,34
Handelsbeginn
35,97
Letzte Trade
3
@
37.8
Letzter Handelszeitpunkt
Finanzvolumen
US$ 26.615.489
VWAP
36,9434
Durchschnittliches Volumen (3 Mio.)
633.377
Ausgegebene Aktien
59.598.018
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-28,38
Gewinn pro Aktie (EPS)
-1,32
Erlöse
60M
Nettogewinn
-78,96M

Über Protagonist Therapeutics Inc

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating se... Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Protagonist Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTGX. The last closing price for Protagonist Therapeutics was US$36,34. Over the last year, Protagonist Therapeutics shares have traded in a share price range of US$ 24,22 to US$ 48,89.

Protagonist Therapeutics currently has 59.598.018 shares in issue. The market capitalisation of Protagonist Therapeutics is US$2,17 billion. Protagonist Therapeutics has a price to earnings ratio (PE ratio) of -28.38.

PTGX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.01-5.0757575757639.639.933.7108839636.15394088CS
4-1.44-3.6894696387439.0339.933.769444237.2282792CS
12-4.37-10.414680648241.9642.76533.763337738.47089263CS
26-4.84-11.407023332542.4348.8933.3166213741.99556049CS
527.5925.33048.8924.2270120837.24529982CS
15613.4755.845771144324.1248.896.9191720822.1101025CS
26030395.2569169967.5950.545.382637523.21809225CS

PTGX - Frequently Asked Questions (FAQ)

What is the current Protagonist Therapeutics share price?
The current share price of Protagonist Therapeutics is US$ 37,59
How many Protagonist Therapeutics shares are in issue?
Protagonist Therapeutics has 59.598.018 shares in issue
What is the market cap of Protagonist Therapeutics?
The market capitalisation of Protagonist Therapeutics is USD 2,17B
What is the 1 year trading range for Protagonist Therapeutics share price?
Protagonist Therapeutics has traded in the range of US$ 24,22 to US$ 48,89 during the past year
What is the PE ratio of Protagonist Therapeutics?
The price to earnings ratio of Protagonist Therapeutics is -28,38
What is the cash to sales ratio of Protagonist Therapeutics?
The cash to sales ratio of Protagonist Therapeutics is 37,35
What is the reporting currency for Protagonist Therapeutics?
Protagonist Therapeutics reports financial results in USD
What is the latest annual turnover for Protagonist Therapeutics?
The latest annual turnover of Protagonist Therapeutics is USD 60M
What is the latest annual profit for Protagonist Therapeutics?
The latest annual profit of Protagonist Therapeutics is USD -78,96M
What is the registered address of Protagonist Therapeutics?
The registered address for Protagonist Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagonist Therapeutics website address?
The website address for Protagonist Therapeutics is www.protagonist-inc.com
Which industry sector does Protagonist Therapeutics operate in?
Protagonist Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
STAKSTAK Inc
US$ 3,97
(156,13%)
173,35k
ORGOOrganogenesis Holdings Inc
US$ 6,21
(102,28%)
58,69M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
192,48M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
136,35M
ARBBARB IOT Group Ltd
US$ 0,6635
(38,23%)
58,86M
NVNINVNI Group Ltd
US$ 0,99
(-50,50%)
72,79M
SPGCSacks Parente Golf Inc
US$ 0,2085
(-48,65%)
58,21M
ADGMAdagio Medical Holdings Inc
US$ 0,8081
(-47,53%)
756,76k
PRAXPraxis Precision Medicines Inc
US$ 38,60
(-40,64%)
3,2M
SAGSAG Holdings Ltd
US$ 1,19
(-38,97%)
789,86k
NVDANVIDIA Corporation
US$ 124,92
(3,97%)
389,48M
TRNRInteractive Strength Inc
US$ 2,57
(67,97%)
193,57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13,44
(7,78%)
154,46M
PMAXPowell Max Ltd
US$ 0,511
(43,54%)
137,18M
LCIDLucid Group Inc
US$ 2,22
(-0,45%)
136,17M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock